Clinical Trial Update: A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration [Phase 2]

View source ↗

Summary

This document summarizes a Phase 2 clinical trial evaluating the Retisert fluocinolone implant for the treatment of wet age-related macular degeneration. The sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Wet Age-related Macular Degeneration

Drugs mentioned

• Retisert (fluocinolone acetonide)

Snippet

Sponsor: Control Delivery Systems | Conditions: Macular Degeneration | Phase 2 | Status: UNKNOWN